Okano F, Saito T, Ido T, Shimizu M. Pharmaceutical composition for treatment and prevention of cancer. US20110129478, 2011.
Leung S. Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 antibodies and uses thereof. US20160363597, 2016.
Staudt LM, Wright GW, Scott DW, et al. Method for subtyping lymphoma types by means of expression profiling. US20160283653, 2016.
West JW, Sagert JG, Hostetter DR, et al. Activatable antibodies that bind interleukin-6 receptor and methods of use thereof. US20170002082, 2017.
Grogan J, Johnston RJ, Irving B, et al. Methods of treating cancer using PD-1 axis binding antagonists and tigit inhibitors. US20170044256, 2017.
Markovic SN, Nevala WK. Methods of using albumin-CD20 paclitaxel nanoparticle complex compositions for treating cancer. US20170182185, 2017.
Kwakkenbos MJ, Wagner K, Bakker AQ. Means and methods for producing stable antibodies. US20170008952, 2017.
Dang L, Fantin V, Gross S, et al. Methods and compositions for cell-proliferation-related disorders. US20170325708, 2017.
Zupancic TJ, Kittle JD, Zeng L, Vedamoorthy S, Brody RS, Williams MR. Universal biosensor system for analyte detection. US20180180608, 2018.
Bilsborough JM. Methods of treating skin disorders using anti-IL-31RA antibodies. US20180244790, 2018.
Liu J, Ring AM, Volkmer JP, Weissman IL. Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRP.alpha. antibody therapy. US20180037652, 2018.
Ast O, Bacac M, Imhof-Jung S, et al. Bispecific T cell activating antigen binding molecules. US20180222981, 2018.
Shachar I, Binsky I, Marom A. Anti CD84 antibodies, compositions comprising same and uses thereof. US20180327493, 2018.
Bossenmaier B, Kettenberger H, Klein C, et al. Monovalent antigen binding proteins. US20180037633, 2018.
Lin K. Methods and compositions for detecting and treating drug resistant AKT mutant. US20180327860, 2018.
Fournier N, Fontayne A, Romeuf C. Anti-CD303 monoclonal antibodies. US20180086834, 2018.
Carrigan CN, Ab O, Tavares D, Wolf BB. Diagnostic assays and kits for detection of folate receptor. US20190227073, 2019.
Kuhn P, Kolatkar A, Kunken J, Marrinucci D, Yang X, Stuelpnagel JR. Method of using non-rare cells to detect rare cells. US20190257834, 2019.
Zhen H. ABCG2 monoclonal antibody and uses thereof. US20190248912, 2019.
Akle C, Grange J, Bilyard K. Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy. US20190008942, 2019.
Ptacin J, Caffaro CE, Milla M. Cytokine conjugates for the treatment of proliferative and infectious diseases. US20190314455, 2019.